A clinical trial used to approve Amgen Inc.’s pill Tavneos was retracted Monday from the New England Journal of Medicine, putting the drug’s continued sales at risk.
Foundation Expands Five-Year Relationship to Include Support for School Districts Facing Deep Budget Cuts The Amgen Foundation, the exclusive sponsor of Khan Academy's biology content, has supported ...
THOUSAND OAKS, Calif., Nov. 16, 2010 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that it now invites applications for its 19th annual Amgen Award for Science Teaching Excellence (AASTE). This ...
THOUSAND OAKS, Calif. and CAMBRIDGE, Mass., Jan. 22, 2020 /PRNewswire/ -- The Amgen Foundation and the Faculty of Arts and Sciences at Harvard University (Harvard FAS) today announced the global ...
THOUSAND OAKS, Calif., June 19, 2013 /PRNewswire/ -- Amgen is pleased to announce the nine science teachers in the United States, Canada and Puerto Rico who are this year's recipients of the Amgen ...
THOUSAND OAKS, Calif., Nov. 16, 2010 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that it now invites applications for its 19th annual Amgen Award for Science Teaching Excellence (AASTE). This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results